Stamford, CT -- (SBWIRE) -- 12/05/2013 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: BNP Paribas SA (ADR) (OTCMKTS:BNPQY), Allianz SE (ADR) (OTCMKTS:AZSEY), AMARANTUS BIOSCI INC (OTCMKTS:AMBS), OncoSec Medical Inc (OTCMKTS:ONCS)
BNP Paribas SA (ADR) (OTCMKTS:BNPQY) ended lower -1.57 percent from its previous close of $36.39 and complete the day at $35.82. The total number of shares changed hands during the day was 216,662. After opening at $35.58, the stock hit as high as $35.99. However, it traded between $24.50 and $37.91 over the last twelve months. BNP Paribas SA provides a range of banking and financial services worldwide. Its retail banking business offers current accounts and other solutions in the areas of corporate financing and asset management; various banking, financial, and insurance products and services; personal loans, consumer credit, and mortgage financing; and equipment finance for corporate clients.
Has BNPQY Found The Bottom and Ready To Move Up? Find Out Here
Allianz SE (ADR) (OTCMKTS:AZSEY) closed yesterday at $16.91, a -0.65% decrease. Around 794,245 shares were traded, beating an-average trading volume of 218,557 shares. The company is now valued at around $76.63 billion. The stock opened the session at $16.79 and touched its highest price point at $16.95.
AZSEY’s lowest price point for the session stood at $16.72 and its 52 week price range stood at $13.06 - $17.55. Allianz SE primarily provides property and casualty, and life/health insurance products to private and corporate customers worldwide. Its Property-Casualty Insurance segment offers various insurance products, including motor liability and own damage, accident, general liability, fire and property, legal expense, credit, and travel insurance products. The company?s Life/Health Insurance segment provides a range of life and health insurance products on individual and group basis comprising annuities, endowment and term insurance, and unit-linked and investment-oriented products, as well as private and supplemental health and long-term care insurance products.
Has AZSEY Found The Bottom And Ready To Gain Momentum? Find Out Here
AMARANTUS BIOSCI INC (OTCMKTS:AMBS) moved +12.24 percent higher at $0.0550 and traded between $0.05 and $0.06 after opening the day at $0.05. Its performance over the last five days remained 24.15%, which stands at 28.21% for a month. Going back further than one month, 1-year performance after recent close was -13.39%. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States. The company is developing the Mesencephalic-Astrocyte-derived Neurotrophic Factor, a therapeutic protein to treat Parkinson?s diseases, as well as for other apoptosis-related disorders, including ischemic heart disease, traumatic brain injury, and orphan diseases.
For How Long AMBS’s Gloss will Attract Investors? Find out via this report
OncoSec Medical Inc (OTCMKTS:ONCS)’s shares dropped, -6.25 percent from its previous close of $0.32 to close at $0.300. The stock is up around 36.36% this year and -6.83% for the last 12 months. Around 1.89 million shares changed hands yesterday, higher from an-average trading volume of 1.22 million shares. OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States. The company is developing technology based on the proprietary use of an electroporation platform to enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse).
Will ONCS Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)